Publication Type : Journal Article
Publisher : Indian Journal of Medical and Paediatric Oncology
Source : Indian Journal of Medical and Paediatric Oncology, 2020;41:138-40, DOI: 10.4103/ijmpo.ijmpo_112_20
Url : https://www.ijmpo.org/ejournals/topic/how-i-treat-epithelial-ovarian-cancer-during-covid-19-pandemic
Campus : Faridabad
School : School of Medicine
Department : General Medicine
Year : 2020
Abstract : Coronavirus disease 2019 (COVID-19) pandemic is accelerating in an unprecedented manner, with 3,175,207 confirmed cases and 224,172 deaths worldwide.[1] Studies from China and Italy reported that individuals with cancer have a two-fold higher rate of COVID-19 infection and a ten-fold higher risk of mortality as compared to individuals patients without cancer.[2], [3], [4] Cancer caregivers are battling in the wake of a scarcity of workforce, personal protective equipment, medications, and risk of COVID-19 infection. This catastrophic situation warrants a relook of management of epithelial ovarian cancer adapted to the local context. Various guidelines on ovarian cancer management and publications of landmark trials were reviewed in this regard, and the latest literature on COVID-19 was studied.[5], [6] These are the suggestions from science and cost-care consortium for managing ovarian cancer patients during the COVID-19 pandemic
Cite this Research Publication : Das CK, Mahindru S, Patel A, Batra A, Biswas B, Mehta P, Pramanik R, Bhethanabhotla S, Gupta VG., "How I treat epithelial ovarian cancer during COVID-19 pandemic," Indian Journal of Medical and Paediatric Oncology, 2020;41:138-40, DOI: 10.4103/ijmpo.ijmpo_112_20